Moleculin Biotech Stock Price - MBRX

0.59
0.02 (3.51%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Moleculin Biotech Inc MBRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0006 0.11% 0.57 0.55 0.5796 0.564 0.5694 00:00:01
Bid Price Ask Price Spread Spread % News
0.56 0.649 0.089 13.71% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
674 320,749 $ 0.5615677 $ 180,122 1,986,451 0.323 - 3.15
Last Trade Time Type Quantity Stock Price Currency
18:48:57 formt 100 $ 0.59 USD

Moleculin Biotech Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 30.34M 53.23M $ -11.88M -0.34 - 51.78M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Moleculin Biotech News

Loading Messages....

Latest MBRX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MBRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.630.670.540.5780946823,166-0.06-9.52%
1 Month0.651.620.3230.59034922,763,900-0.08-12.31%
3 Months0.961.620.3230.70221851,560,734-0.39-40.63%
6 Months1.021.620.3230.7468345837,806-0.45-44.12%
1 Year0.9613.150.3231.571,369,876-0.391-40.69%
3 Years1.073.750.3231.85973,554-0.50-46.73%
5 Years8.999.580.3231.86832,970-8.42-93.66%

Moleculin Biotech Description

Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis.


Your Recent History
NASDAQ
MBRX
Moleculin ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.